Is Myrtol® Standardized a New Alternative toward Antibiotics?
| Autor: | Adrian Gillissen, Maria Paparoupa |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Chronic bronchitis
medicine.medical_specialty Pediatrics medicine.drug_class Antibiotics Pulmonary disease Plant Science GeloMyrtol® 01 natural sciences 03 medical and health sciences Phytomedicine 0302 clinical medicine In vivo Antibiotic therapy Internal medicine Review Study GeloMyrtol® forte Drug Discovery Medicine 030212 general & internal medicine Medical prescription Pharmacology mechanisms indications 010405 organic chemistry business.industry 0104 chemical sciences Complementary and alternative medicine Myrtol® standardized business Ex vivo |
| Zdroj: | Pharmacognosy Reviews |
| ISSN: | 0976-2787 0973-7847 |
| Popis: | GeloMyrtol® and GeloMyrtol® forte, also known as Myrtol® standardized, is an herbal medical product (phytomedicine) obtained by a multistep distillation procedure from essential oils. The major biological marker of in vivo and ex vivo activity of Myrtol® standardized is the monoterpenes, d-limonene, 1,8-cineole, and alpha-pinene. Myrtol® standardized is estimated to have antioxidative, anti-inflammatory, and antibacterial potential while many studies confirmed its secretolytic and bronchospasmolytic effects. As such, the medication is proposed to be initiated in several acute and chronic infections of the upper and lower airway system as acute and chronic rhinosinusitis, acute and chronic bronchitis, and chronic obstructive pulmonary disease. This review intends to give an insight into several prescription indications of Myrtol® standardized, all involved mechanisms, and potential advantages toward antibiotic therapy, especially in cases when bacterial infection is uncertain. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|